Catalyst Wire Dossier Catalyst Wire Dossier

Yupelri

revefenacin · Sunovion Pharmaceuticals
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Yupelri, covering 2018-11-09 to 2025-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Revefenacin in Acute Respiratory Insufficiency in COPD [Phase 2]

See pricing